A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.
More in Research
This “rare” autism-linked genetic disorder may be far more common than scientists thought
September 25, 2026
CRISPR could help doctors attack blood cancer without destroying healthy cells
September 25, 2026
CERN has begun disconnecting the Large Hadron Collider
September 25, 2026
Quantum computing’s “dark horse” just proved it can go universal
September 25, 2026
Earth is tearing apart beneath the Pacific Northwest
September 25, 2026
Scientists gave worms magnetic bacteria. They lived 43% longer
September 25, 2026
Latest News
Four American tourists among 6 killed in suspected gas leak blast in Athens
September 26, 2026
Powerful storm brings flooding, power outages to northeastern United States
September 26, 2026
Deadly shooting hits Caribbean islands of Saint Vincent and the Grenadines
September 26, 2026
Asian Games 2026 LIVE Day 9: Priyanka, Manju eye early racewalk medals for India; Manu Bhaker in action later
September 26, 2026
Trump rejects Iran deal to reopen Strait of Hormuz in seven days
September 26, 2026
Student protesters disrupt NVIDIA AI climate panel
September 26, 2026